Every AI newsletter, investors ask questions on the investor interaction platform: Hello, secretary. Whether the company has any plans to carry out the NMN production of “not old medicine” in the future, thank you!
Jilin Aodong Pharmaceutical Group Co.Ltd(000623) ( Jilin Aodong Pharmaceutical Group Co.Ltd(000623) . SZ) said on the investor interaction platform on April 2 that the company currently has no layout in the field of longevity drugs. However, relevant personnel have been arranged to further understand the relevant information of “NMN” and arrange the next work in combination with the actual situation.
